Stock Track | CareDx Stock Soars 15.36% After Hours on Strong Q3 Earnings Beat

Stock Track11-05

Shares of CareDx (NASDAQ: CDNA) jumped 15.36% in after-hours trading on Tuesday following the release of the company's third-quarter financial results that significantly exceeded analyst expectations.

The transplant diagnostics company reported adjusted earnings per share of $0.28, which was more than double the analyst consensus estimate of $0.14. This represents a 100% increase from the same period last year when the company earned $0.14 per share. Revenue for the quarter came in at $100.1 million, surpassing the analyst forecast of $95.25 million and marking a 20.72% year-over-year growth from $82.88 million.

CareDx's strong performance was driven by a 19% increase in testing services revenue, which reached $72.2 million. The company also saw a 13% growth in testing services volume, processing 50,300 tests during the quarter. Additionally, CareDx reported a GAAP net income of $1.7 million, a significant improvement from a net loss of $10.6 million in the same quarter of 2024. The company's adjusted EBITDA more than doubled to $15.3 million from $6.9 million year-over-year.

Following these impressive results, CareDx raised its full-year 2025 revenue guidance to a range of $372 million to $376 million. The company also increased its adjusted EBITDA forecast to between $35 million and $39 million. The strong earnings report and improved outlook have clearly resonated with investors, driving the substantial after-hours stock price increase.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1195278284?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-05 05:34","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1195278284","market":"us","top_or_hot":-1,"title":"Stock Track | CareDx Stock Soars 15.36% After Hours on Strong Q3 Earnings Beat","media":"Stock Track","content":"<p>Shares of CareDx (NASDAQ: CDNA) jumped 15.36% in after-hours trading on Tuesday following the release of the company's third-quarter financial results that significantly exceeded analyst expectations.</p>\n\n<p>The transplant diagnostics company reported adjusted earnings per share of $0.28, which was more than double the analyst consensus estimate of $0.14. This represents a 100% increase from the same period last year when the company earned $0.14 per share. Revenue for the quarter came in at $100.1 million, surpassing the analyst forecast of $95.25 million and marking a 20.72% year-over-year growth from $82.88 million.</p>\n\n<p>CareDx's strong performance was driven by a 19% increase in testing services revenue, which reached $72.2 million. The company also saw a 13% growth in testing services volume, processing 50,300 tests during the quarter. Additionally, CareDx reported a GAAP net income of $1.7 million, a significant improvement from a net loss of $10.6 million in the same quarter of 2024. The company's adjusted EBITDA more than doubled to $15.3 million from $6.9 million year-over-year.</p>\n\n<p>Following these impressive results, CareDx raised its full-year 2025 revenue guidance to a range of $372 million to $376 million. The company also increased its adjusted EBITDA forecast to between $35 million and $39 million. The strong earnings report and improved outlook have clearly resonated with investors, driving the substantial after-hours stock price increase.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | CareDx Stock Soars 15.36% After Hours on Strong Q3 Earnings Beat</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | CareDx Stock Soars 15.36% After Hours on Strong Q3 Earnings Beat\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-11-05 05:34</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shares of CareDx (NASDAQ: CDNA) jumped 15.36% in after-hours trading on Tuesday following the release of the company's third-quarter financial results that significantly exceeded analyst expectations.</p>\n\n<p>The transplant diagnostics company reported adjusted earnings per share of $0.28, which was more than double the analyst consensus estimate of $0.14. This represents a 100% increase from the same period last year when the company earned $0.14 per share. Revenue for the quarter came in at $100.1 million, surpassing the analyst forecast of $95.25 million and marking a 20.72% year-over-year growth from $82.88 million.</p>\n\n<p>CareDx's strong performance was driven by a 19% increase in testing services revenue, which reached $72.2 million. The company also saw a 13% growth in testing services volume, processing 50,300 tests during the quarter. Additionally, CareDx reported a GAAP net income of $1.7 million, a significant improvement from a net loss of $10.6 million in the same quarter of 2024. The company's adjusted EBITDA more than doubled to $15.3 million from $6.9 million year-over-year.</p>\n\n<p>Following these impressive results, CareDx raised its full-year 2025 revenue guidance to a range of $372 million to $376 million. The company also increased its adjusted EBITDA forecast to between $35 million and $39 million. The strong earnings report and improved outlook have clearly resonated with investors, driving the substantial after-hours stock price increase.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"CDNA","symbol_name":"CareDx","start_time":0,"source_url":"","article_id":"1195278284","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1195278284","pubTimestamp":1762292087,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Shares of CareDx (NASDAQ: CDNA) jumped 15.36% in after-hours trading on Tuesday following the release of the company's third-quarter financial results that significantly exceeded analyst...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"CDNA":"CareDx"},"translate_title":"股票追踪|CareDx股价盘后飙升15.36%，第三季度盈利强劲","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CDNA":1},"content_text":"Shares of CareDx (NASDAQ: CDNA) jumped 15.36% in after-hours trading on Tuesday following the release of the company's third-quarter financial results that significantly exceeded analyst expectations.\nThe transplant diagnostics company reported adjusted earnings per share of $0.28, which was more than double the analyst consensus estimate of $0.14. This represents a 100% increase from the same period last year when the company earned $0.14 per share. Revenue for the quarter came in at $100.1 million, surpassing the analyst forecast of $95.25 million and marking a 20.72% year-over-year growth from $82.88 million.\nCareDx's strong performance was driven by a 19% increase in testing services revenue, which reached $72.2 million. The company also saw a 13% growth in testing services volume, processing 50,300 tests during the quarter. Additionally, CareDx reported a GAAP net income of $1.7 million, a significant improvement from a net loss of $10.6 million in the same quarter of 2024. The company's adjusted EBITDA more than doubled to $15.3 million from $6.9 million year-over-year.\nFollowing these impressive results, CareDx raised its full-year 2025 revenue guidance to a range of $372 million to $376 million. The company also increased its adjusted EBITDA forecast to between $35 million and $39 million. The strong earnings report and improved outlook have clearly resonated with investors, driving the substantial after-hours stock price increase.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"2","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.10","shortVersion":"4.35.10","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1195278284","isCrawlerRequest":true}